Dr. Jay Bhattacharya on Restoring Trust in Science and the Future of NIH Research
What this video covers
Host Dr. Drew Pinsky welcomes Bhattacharya — introduced as a longtime friend, physician, epidemiologist, former Stanford professor, and now NIH director — for a conversation about his transition into government and his agenda for the agency. The tone is sympathetic: two physicians discussing how to rebuild a scientific establishment both men argue has lost the public’s confidence.
The central policy flashpoint is mRNA vaccine research. Bhattacharya responds to criticism from the American Medical Association over the NIH’s shift away from funding mRNA vaccine work for respiratory viruses. His argument, as presented in the video: public trust in the mRNA platform has collapsed — he cites a study showing 60% of Americans said they would never take another COVID vaccine with mRNA in it, and that only about one in four were following CDC guidance — so it is better to invest in other vaccine technologies, such as whole-virus inactivated vaccines that the public has not lost confidence in. He stresses he is not blocking the mRNA platform itself: he calls it promising for cancer, where the calculation is very different, and says the NIH is funding applications there.
He also emphasizes funding research on long COVID and supporting people with vaccine injuries, and returns to his core theme: restoring trust in science through transparency, open dialogue, and acknowledging past mistakes. Both he and Dr. Drew stress that rebuilding credibility requires humility, honesty, and a commitment to evidence-based medicine. In one striking line, Bhattacharya says scientists and public-health officials should be “servants of the people, not lords of the people.” He adds that he wants to surround himself with bright people who disagree with him — “I want to foster conversations rooted in evidence,” not “devastating takedowns.”
Key points
- Bhattacharya says public trust in the mRNA vaccine platform has collapsed, justifying the NIH’s shift of respiratory-virus funding toward other vaccine technologies — while keeping mRNA research alive for cancer applications.
- He grounds the shift in numbers: 60% of Americans said they would never take another mRNA COVID vaccine, and only about one in four were following CDC guidance.
- He answers AMA criticism of that shift directly, framing it as a response to public confidence rather than an attack on the science — and argues whole-virus inactivated vaccines are a promising alternative the public still trusts.
- He pledges NIH support for long COVID research and for people who report vaccine injuries.
- His stated formula for restoring trust: transparency, open dialogue, and institutional acknowledgment of mistakes — and he says scientists and public-health officials should be “servants of the people, not lords of the people.”
- Both interviewer and guest agree that humility and honesty are prerequisites for evidence-based medicine to regain credibility.